Kotsiou A, Tsamouri M, Anagnostopoulou S, Tzivras M, Vairactaris E, Tesseromatis C
Eur J Drug Metab Pharmacokinet. 2006; 31(2):97-101.
PMID: 16898077
DOI: 10.1007/BF03191125.
Nishi S, Shindo M, Abe J, Asada A
Br J Clin Pharmacol. 1998; 45(1):41-7.
PMID: 9489593
PMC: 1873989.
DOI: 10.1046/j.1365-2125.1998.00641.x.
Brashear R, Nelson R, Glick M, Oei T, DeAtley R
Lung. 1980; 158(2):101-9.
PMID: 7431995
DOI: 10.1007/BF02713709.
Seefeld M, Albrecht R, Gilchrist K, Peterson R
Arch Environ Contam Toxicol. 1980; 9(3):317-27.
PMID: 7396554
DOI: 10.1007/BF01057411.
Pirttiaho H, Sotaniemi E, Pelkonen R, Pitkanen U, Anttila M, Sundqvist H
Br J Clin Pharmacol. 1980; 9(4):399-405.
PMID: 7378257
PMC: 1429970.
DOI: 10.1111/j.1365-2125.1980.tb01068.x.
Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver.
Luoma P, Sotaniemi E, Pelkonen R, Arranto A, Ehnholm C
Eur J Clin Pharmacol. 1982; 23(3):275-82.
PMID: 7173298
DOI: 10.1007/BF00547568.
Elimination of pindolol in liver disease.
Ohnhaus E, Munch U, Meier J
Eur J Clin Pharmacol. 1982; 22(3):247-51.
PMID: 7106158
DOI: 10.1007/BF00545223.
Effects of hepatic function on vancomycin clinical pharmacology.
Brown N, Ho D, Fong K, Bogerd L, Maksymiuk A, Bolivar R
Antimicrob Agents Chemother. 1983; 23(4):603-9.
PMID: 6859839
PMC: 184709.
DOI: 10.1128/AAC.23.4.603.
Pharmacokinetics of oral brotizolam in patients with liver cirrhosis.
Jochemsen R, Joeres R, Wesselman J, Richter E, Breimer D
Br J Clin Pharmacol. 1983; 16 Suppl 2:315S-322S.
PMID: 6661377
PMC: 1428219.
DOI: 10.1111/j.1365-2125.1983.tb02306.x.
The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.
Ohnhaus E, Berger W, DUCKERT F, Oesch F
Klin Wochenschr. 1983; 61(17):851-8.
PMID: 6632727
DOI: 10.1007/BF01537460.
Clinical pharmacokinetics of narcotic agonist-antagonist drugs.
Bullingham R, McQuay H, Moore R
Clin Pharmacokinet. 1983; 8(4):332-43.
PMID: 6352139
DOI: 10.2165/00003088-198308040-00004.
Detection of reticulo-endothelial blockade with low-dose test agent.
Chadwick S, Aldridge M, Dudley H
Br J Exp Pathol. 1985; 66(4):483-91.
PMID: 4027180
PMC: 2041097.
Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver.
Stenderup J, Eriksen J, Pedersen S, Christiansen L
Eur J Clin Pharmacol. 1985; 28(5):573-9.
PMID: 3876221
DOI: 10.1007/BF00544069.
The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration.
Wood A, Kornhauser D, Wilkinson G, SHAND D, Branch R
Clin Pharmacokinet. 1978; 3(6):478-87.
PMID: 719984
DOI: 10.2165/00003088-197803060-00005.
Liver size and indices of drug metabolism in epileptics.
Pirttiaho H, Sotaniemi E, Ahokas J, Pitkanen U
Br J Clin Pharmacol. 1978; 6(3):273-8.
PMID: 687506
PMC: 1429461.
DOI: 10.1111/j.1365-2125.1978.tb04597.x.
Drug metabolism in epileptics: in vivo and in vitro correlations.
Sotaniemi E, Pelkonen R, Ahokas J, Pirttiaho H, Ahlqvist J
Br J Clin Pharmacol. 1978; 5(1):71-6.
PMID: 619937
PMC: 1429229.
DOI: 10.1111/j.1365-2125.1978.tb01600.x.
Impairment of drug metabolism in polycystic non-parasitic liver disease.
Sotaniemi E, Luoma P, Jarvensivu P, Sotaniemi K
Br J Clin Pharmacol. 1979; 8(4):331-5.
PMID: 508507
PMC: 1429841.
DOI: 10.1111/j.1365-2125.1979.tb04714.x.
The effect of carbon tetrachloride (CCl4) induced liver damage on the volume of distribution, the elimination half-life and body clearance of antipyrine and warfarin in rabbits.
Ladefoged O
Acta Vet Scand. 1979; 20(3):429-37.
PMID: 506875
PMC: 8322888.
Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration.
Ueda C, Dzindzio B
Eur J Clin Pharmacol. 1979; 16(2):101-5.
PMID: 499305
DOI: 10.1007/BF00563115.
Hepatic reactions to drugs.
Sherlock S
Gut. 1979; 20(7):634-48.
PMID: 488760
PMC: 1412519.
DOI: 10.1136/gut.20.7.634.
